Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10592008 | 0.77 | GABRA1 (0.44) | GABRA1GABRB2CA1CA2PTPN1 | |
| SCHEMBL4886853 | 0.74 | — | — | |
| SCHEMBL4889308 | 0.74 | GABRA1 (0.48) | GABRA1GABRB2 | |
| SCHEMBL11807767 | 0.70 | GABRA1 (0.46) | GABRA1GABRB2LMNA | |
| SCHEMBL4886962 | 0.70 | CA2 (0.31) | CA1CA2 | |
| SCHEMBL10799329 | 0.66 | GABRA1 (0.42) | GABRA1GABRB2LMNA | |
| SCHEMBL17873619 | 0.66 | GABRA1 (0.55) | GABRA1GABRB2LMNA | |
| SCHEMBL4882830 | 0.65 | THRB (0.42) | LMNACA2 | |
| SCHEMBL9018772 | 0.65 | GABRA1 (0.38) | GABRA1GABRB2LMNACA1CA2 | |
| SCHEMBL12658939 | 0.65 | GABRA1 (0.68) | GABRA1GABRB2CA1CA2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | AR, AHR, BCL6 | GABRA1 2034/4885GABRB2 2521/4885LMNA 2555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.